t,-A tumor model involving stereotactically implanted culture-reared tumor cells is presented. Stainless steel cannulas were stereotactically and permanently implanted into the eaudate nucleus of 30 rats. The animals were separated into two groups. In Group I. 15 animals received a 10-ul injection containing 106 C6 glioblastoma cells (five rats), 106 Walker 256 breast carcinoma cells (five rats), or cell medium (five rats). The coordinates were A(+l.5), L(+3.0), and DV(-5.0). In Group II, the coordinates were changed to A(+I.0), L(+3.0), and DV(-5.0) and the same number of rats received a l-ul injection containing 105 cells of each tumor in an attempt to produce more focal tumors. Two weeks after implantation, brain sections were stained with cresyl violet and a subset was stained for glial fibrillary acidic protein (GFAP). A computerized morphometric analysis system was used to quantify' tumor size. In Group I, the mean C6 tumor areas (+ standard error of the mean) at specific coordinates were (in sq mm): A(+4.7) 0.4 + 0.2; A(+3.7) 3.5 + 1.1; A(+2.7) 5.7 _+ 1.7; A(+I.7) 9.5 + 2.3; A(+0.7) 7.5 -4-3.2; A(-0.3) 3.7 _+ 2.9; and A(-I.3) 0.3 -+ 0.3. A nearly identical tumor mass and extension into the brain was produced in rats injected with Walker 256 cells. Similar C6 tumor areas were indicated in adjacent sections stained with cresyl violet and GFAP. Tumor was found in the eaudate nucleus in all 10 rats, but not in the nucleus accumbens, fornix, or hippocampus. In Group II animals, tumor magnitude and extension into the brain were greatly reduced. The 106 ceils in the 10-ul volume was the most reliable tumor load for obtaining uniform tumors in different animals. The similarity of tumor distribution across different animals was indicated by the low variance of tumor area at specific anteroposterior coordinates. Reproducible and well-circumscribed caudate nucleus tumors were produced using this stereotactic procedure.
T

HE median survival time of individuals diagnosed
as having malignant brain tumors is usually less than 1 year. 7"2~' 27 Therefore, it is necessary to develop reliable and precise models of brain tumors in animals in order to understand factors that modulate the growth of brain tumors and to develop treatments that inhibit these tumors. A variety of brain-tumor models have been reported. 1"611"24 Models vary with respect to animal host, 2-18.22,32 type of tumor used, 5 ~0. 16 .25 method of tumor production, location of tumor, size of tumor, and tumor growth time. A number of chemically induced tumors have been studied, including C6 glioma (which is a malignant astrocytoma derived from chemically induced rat astrocytes), schwannoma, and others. 2"~4"~8 Numerous types of chemicals have been used to induce brain tumors in rats. 3"8"13"15"19"23"29"31"32 A variety of routes of administration of carcinogenic substances to animals have been utilized to induce brain tumors, including oral, subcutaneous, intravenous, and intracerebral. 8''2"31 '32 One method for producing brain tumors in rats is by injecting tumor cells into the cerebrovasculature. Ushio, et al., 25 injected W256 carcinoma cells into the carotid artery of rats; however, intracerebral growth yields were poor (about 25%), and massive extracerebral metastases were common. The next development was the intracisternal injection of W256 carcinoma cell suspensions into rats, which produces a widespread meningeal carcinomatosis. 24 A more precise approach involves the free-hand injection of tumor cells into particular areas of rat brain, 2~ but this method has been criticized for its lack of reliability, poor intracerebral growth yields, and rapid spread to extracranial tissue. ~ Some free-hand injection methods in which neoplastic glial cells are injected into the frontal cortex of rats do yield a 100% tumor take; ~ however, even this method results in extracerebral masses in about one-half of the animals. Finally, Kobayashi, el al., ~1 found that stereotactic implantation of tumor into the rat brain (caudate nucleus) resulted in a more reliable tumor model, with a 99% to 100% yield of intracerebral tumor as well as a marked reduction in extracranial extension.
We present a stereotactic procedure for the implantation of a discrete number of cultured tumor cells (malignant rat astrocytes or rat breast carcinoma) into the caudate nucleus of the rat brain. Our model offers a further refinement of the method described by Kobayashi, etal., ~ by using a permanently implanted stainless steel cannula to decrease the spread of tumor along the injection line. A computer morphometric analysis of tumors offers a precise and objective method for quantifying the spread of tumor into the brain.
Materials and Methods
Tumor Cells and Hosts
Thirty male Wistar rats, each weighing 200 to 250 gin, were used for this study.* Rats were individually housed in Plexiglas cages and given free access to standard laboratory rat chow and water. The room was maintained on a 12-hour day/night cycle at 22.2~
The donor C6 cells were 40th-passage C6 gliomaastrocsr cells obtained as a culture. This cell line is derived from N-methylnitrosourea-transformed rat astrocytes. The donor Walker 256 cells 9 were 65th-passage LLC-Walker 256 rat breast carcinoma cells obtained as a culture. Cell culturest were grown by W. J. Goidberg, Ph.D., according to the method of Bernstein, etal. 2 
Mounting the Guide Cannula
The rats were deprived of food and water 12 hours before surgery. They were deeply anesthetized with pentobarbital (Nembutal), 42 mg/kg, by intraperitoneal injection. The head was mounted into a stereotactic head holder in a flat-skull position determined by equalizing the dorsal-ventral (DV) distance (within 0.05 ram) at the intersection of the bregma at the midline and the lambda at the midline. A burr hole was made using a 1.4-mm diamond-tipped burr at the following coordinates: Group I: anterior 1. 
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skull top followed by raising it to DV(-5.0) to make an injection "pocket." It was hypothesized that creating a pocket for the cells to settle into during injection would minimize the spread of tumor cells up the cannula tract. The guide cannula was held in place by cranioplastic cement and cemented to four k-in. stainless steel screws mounted to the cranium.w The guide cannula was capped with a dummy styler that extended 1.0 mm beyond the tip of the guide cannula in order to insure that the guide cannula was clear.
Injecting the Cells"
The cells were maintained in suspension by constant agitation and the suspension was injected using a 50-ul syringe. Attached to the syringe was a 5.0-cm piece of polyethylene (PE-20) tubing and a No. 28 stainless steel injection cannula. The cell concentration was rechecked just prior to implantation. 11 The syringe assembly was mounted on a Harvard syringe pump calibrated to deliver 1 #1 over 3 minutes.* The injection cannula was inserted into the guide cannula. Either the cell suspension or the medium was injected over a period of 10 minutes for Group I and 3 minutes for Group II. In Group I, three sets of five rats each were injected with either 1.0 x 10 6 C6 cells in 10 ~1 phosphate-buffered saline (PBS)-glucose medium, 1.0 x l0 b Walker 256 cells in i0 ~1 PBS-glucose medium, or I O #1 PBS-glucose medium (control rats). In Group II, three sets of five rats each were injected with 1.0 x L05 C6 cells in 1 ul PBS-glucose medium, 1 x l0 s Walker 256 cells in 1 ul PBS-glucose medium, or I Fzl PBS-glucose medium (control rats). After injection, the injector remained inside the guide cannula for 5 minutes to allow the injected cell suspension or medium to come to equilibrium inside the brain. The injector was then removed and the dummy cannula was inserted and secured.
Tissue Collection and Processing
The animals were sacrificed 2 weeks after implantation. They were deeply anesthetized with intraperitoneal pentobarbital (50 mg/kg). Group I animals were perfused with normal saline followed by a mixture of formalin, ethanol, and acetic acid (FEA), and Group II animals were perfused with normal saline followed by Bouin's solution (15 U saturated picric acid, 5 U formaldehyde solution, I U glacial acetic acid). The perfusion medium was changed from FEA to Bouin's solution since the latter is a better fixative for immunocytochemical staining of certain neurochemicals.
The brains were dehydrated and embedded in paraffin. Serial coronal sections of 14 um thickness were cut throughout the forebrain. Four sections were placed on each slide, and every 10th slide was stained for cresyl violel. In four Group I C6 animals, select slides were stained for glial fibrillary acidic protein (GFAP).
w Cranioplastic cement and stainless steel screws manufactured by Plastic Products, Roanoke, Virginia.
11 Hemocytometer manufactured by American Optical, Buffalo, New York.
* Syringe pump obtained from Harvard Apparatus, Millis, Massachusetts.
Morphornetric A nalysis
First, anterior-posterior (A-P) coordinates for each slide stained with cresyl violet and GFAP were determined using a stereotactic rat atlas ~7 by an observer who was blind to the origin of each slide. Second, following these coordinate determinations, morphometric analysis was done using a Loats RAS-1000 system and the tumor and brain areas were determined. Within Groups I and II, the mean tumor area _+ standard error of the mean was calculated for each of the three subgroups (C6, W256, and culture medium, with five animals per group) at designated A-P coordinates from +5.7 to -2.3 (from the bregma) at l-mm intervals, and slices were assigned to these A-P l-ram serial coordinates by estimating anterior or posterior by _+ 0.5 ram.
Results
Tumor Production
In Group I animals, injection of 106 C6 and 10 6 W256 cells resulted in tumor being produced in all five rats of both groups. Similarly, in Group II animals, 105 C6 and l05 W256 cells resulted in tumor in all five rats of both groups.
Morphology
There was no invasion of the fornix, nucleus accumbens, or hippocampus, nor evidence of hydrocephalus for either of the groups. Representative sections are presented in Fig. 1 and described Gross inspection of the cresyl violet-stained slides revealed that all of the tumors were unifocal masses originating in the right caudate nucleus. Four rats had tumors that extended to the area of the frontal cortex immediately above the corpus callosum. One rat had a tumor with a large enough mass to distort the fight lateral ventricle. In four rats, C6 cells were found in the ventricular system and subependymal area and, in four, the cells grew through the corpus callosum. Four of the five C6 tumors had a cystic component and two had central regions of necrosis. Figure 2 compares two rats implanted with C6 tumors (both 106 cells) at various A-P coordinates showing the extension of these tumors in the brain. The reliability of the model is indicated by the similarity in the distribution of the C6 tumor in these two rats and in others described below at defined A-P coordinates ranging from the most anterior to the most posterior. Group H. A coronal section taken through the middle of a C6 tumor (AP(+I.7), 10 > C6 cells) is shown in Fig. 1 lower leJL The injected bulk of tumor mass was reduced by 10-fold in comparison with that received by the Group I C6 cell recipients (compare with Fig. 1 upper left). Each of the tumors was subconical and completely enclosed within the right caudate nucleus; there was no distortion of the right lateral ventricle or gross invasion of the corpus callosum. In one rat, C6 cells were found in the ventricular system and subependymal area. Two of the five C6 tumors in Group II showed cystic components and two had areas of central necrosis. 
Morphometric Analysis
Grmtp I. Figure 3 upper pair shows the brain-tumor profiles for C6 and W256 tumors at specific A-P coordinates (10 ~' cells injected in 10 ul PBS-glucose medium). The largest cross-sectional tumor area was centered approximately at the injection site, A(+l.5). The C6 tumors extended anteriorly 1.0 mm further than W256 tumors but posterior extension was the same for the two cell types (Fig. 3 upper pair) . The 
Histological Findings
C6 Tumors. Staining of the C6 cells from Group I rats for GFAP showed that the C6 cells had large nuclei and possessed abundant cytoplasm, and there were many thick, short processes extending in all directions. The sections showed crowded C6 cells overlapping in the center of the tumor with occasional areas of cyst formation and necrosis. Surrounding the tumor were individual C6 cells migrating into the brain parenchyma. The C6 cells were found in the corpus callosum, the subependymal area, and along the blood vessels. There was no evidence of secondary tumor formation. Morphometric analysis of tumor areas at the same coordinate (largest diameter), stained with cresyl violet or GFAP, in four rats injected with C6 cells in 10 ul failed to indicate a significant difference in the tumor areas shown by these two staining techniques (cresyl violet 10.76 + 7.81, GFAP 10.57 _+ 8.08; t(3) = 0.75, and p > 0.10).
W256 Tumors. The W256 cells of Group I rats in sections stained with cresyl violet exhibited round ceils with large nuclei. The cells were arranged in a whorled pattern at the center of the tumor. There was rare cyst formation and occasional tumor necrosis; no evidence was found of cell migration away from the tumor mass or of secondary tumor formation.
Discussion
Highly reproducible tumors were produced in rats using a stereotactic procedure involving implantation of a permanent stainless steel cannula and injection of cultured celis into the caudate nucleus. All masses were well localized and originated at the right caudate nucleus, and no secondary masses were produced. There was no extension of tumor up the injection track or around the stainless steel cannula as occurs with injection via a syringe. 4'~26 By comparison, seeding of tumor cells along the line of injection is almost always the case with free-hand systems. The number of cells used in both groups (10 b and 105 ) was sufficient to produce tumor for both C6 and W256 cell types in 100% of cases. Reduction in cell number from 106 to 105 cells and injection volume from 10 to 1 ul greatly decreased C6 and W256 tumor magnitude and the distribution along the A-P axis. The relatively greater tumor mass produced by the 1-ul (105 cells) injection of W256 tumors versus C6 cells is not explained. This may be an artifact of the small sample size combined with the decreased reliability of the smaller ( 1 ul) tumor volume.
With staining for GFAP it was possible to morphologically distinguish C6 cells from normal astrocytes in the host brain? As noted by Bernstein, et aL, 2 C6 cells had larger cell bodies, larger nuclei, and less extensive but thicker and shorter cell processes than normal astrocytes. In rats injected with 106 cells (I0 ul), individual C6 cells were found in the corpus callosum, in the subependymal area, and in the surrounding blood vessels. It has been shown that C6 cells migrate along such structures. 2 By comparison, the injected W256 cells formed a discrete round mass centered on the injection site. The pattern of growth of the tumor mass V. M. Morreale, et aL was similar to the tumors produced by intracarotid injection of W256 cells 3~ except that there were no secondary, areas of tumor seeding. The tumor borders were well circumscribed.
Morphometric analysis of C6 tumors with GFAP and cresyl violet staining yielded similar tumor areas. Cresyl violet (a nuclear stain) stains cell bodies while GFAP specifically stains GFAP in the cell processes of the C6 cells and host brain astrocytes. Our results indicate that cresyl violet is sufficient to achieve morphometric analysis of C6 gliomas and W256 tumor areas.
An advantage of our system is that it is not limited to any particular tumor or brain site. The reproducibility of the model makes it useful for investigating the effects of drugs on brain-tumor growth and inhibition in vivo. lndeed, the presence of a permanent cannula at the center of the tumor offers a unique opportunity to examine the effects of focal application of chemotherapeutic agents directly into the tumor mass. Such an approach would bypass the blood-brain barrier. This model may be useful as a standard for various types of brain-tumor studies.
